FDA product code OQX: Self-Contained Blood Grouping

OQX is the FDA product code for self-contained blood grouping. It is a Class II device, regulated under 21 CFR 864.9175 and reviewed by the Hematology panel. Devices under OQX reach the market by 510(k); FDA lists no cleared 510(k)s for it. FDA has posted 1 recall for OQX devices, 1 initiated in the last five years.

Definition

Intended for single use for individual blood group determination for educational and informational purposes

Classification

FieldValue
Device nameSelf-Contained Blood Grouping
Device classClass II
Regulation21 CFR 864.9175
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k)

Recalls for OQX devices

1 product recalls in 1 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2025-11-03.

YearRecalls
20251

Frequently asked questions

What is FDA product code OQX?

OQX is the FDA product code for self-contained blood grouping. It is a Class II device, regulated under 21 CFR 864.9175 and reviewed by the Hematology panel.

What device class is OQX?

Class II, regulation 21 CFR 864.9175. Typical premarket route: 510(k).

Have OQX devices been recalled?

Yes: 1 product recalls across 1 recall events; the most recent began 2025-11-03.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times